RESEARCH COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN GILEAD SCIENCES, INC. AND HOOKIPA BIOTECH AGResearch Collaboration and License Agreement • March 19th, 2020 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 19th, 2020 Company Industry JurisdictionThis RESEARCH COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is made as of June 4, 2018 (the “Effective Date”), by and between Gilead Sciences, Inc., a Delaware corporation having an office at 333 Lakeside Drive, Foster City, CA 94404 (“Gilead”) and Hookipa Biotech AG, an Austrian corporation (Aktiengesellschaft) having an office at St Marx Vienna Bio Center: Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria (“Hookipa”). Gilead and Hookipa are each referred to individually as a “Party” and together as the “Parties.”
CONSULTANCY AGREEMENTConsultancy Agreement • March 19th, 2020 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Contract Type FiledMarch 19th, 2020 Company Industry
Funding Contract concluded between The Austrian Research Promotion Agency (FFG) as Funding Agency and HOOKIPA Biotech AG Helmut-Qualtinger-Gasse 2 Commercial register no. FN 365895g as Funding Recipient. Sec. 1 Granting fundsHOOKIPA Pharma Inc. • March 19th, 2020 • Pharmaceutical preparations
Company FiledMarch 19th, 2020 Industry